Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Intangibles (2020 - 2022)

Historic Intangibles for Ovid Therapeutics (OVID) over the last 3 years, with Q1 2022 value amounting to $244000.0.

  • Ovid Therapeutics' Intangibles fell 722.43% to $244000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $244000.0, marking a year-over-year decrease of 722.43%. This contributed to the annual value of $263000.0 for FY2021, which is 1755.49% down from last year.
  • Latest data reveals that Ovid Therapeutics reported Intangibles of $244000.0 as of Q1 2022, which was down 722.43% from $263000.0 recorded in Q4 2021.
  • Over the past 5 years, Ovid Therapeutics' Intangibles peaked at $436000.0 during Q1 2020, and registered a low of $197000.0 during Q3 2021.
  • Over the past 3 years, Ovid Therapeutics' median Intangibles value was $263000.0 (recorded in 2021), while the average stood at $290625.0.
  • Its Intangibles has fluctuated over the past 5 years, first plummeted by 3967.89% in 2021, then crashed by 722.43% in 2022.
  • Ovid Therapeutics' Intangibles (Quarter) stood at $319000.0 in 2020, then fell by 17.55% to $263000.0 in 2021, then decreased by 7.22% to $244000.0 in 2022.
  • Its last three reported values are $244000.0 in Q1 2022, $263000.0 for Q4 2021, and $197000.0 during Q3 2021.